This indicates that although early activation of CD8 T cells in TDLNs occurs unimpeded in STL mice, the overall decrease in CD8 T cell numbers limits the efficient clonal amplification of tumor-reactive PD-1+ CD8 T cells. This evidence concerns the gene CD8A and neoplasm.